Impact of Discrepancies in General and Abdominal Obesity on Major Adverse Cardiac Events

被引:54
作者
Choi, Daein [1 ,2 ]
Choi, Seulggie [1 ]
Son, Joung Sik [3 ]
Oh, Sang Woo [4 ]
Park, Sang Min [1 ,3 ]
机构
[1] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea
[2] Pyeongchang Hlth Ctr & Cty Hosp, Pyeongchang, South Korea
[3] Seoul Natl Univ, Dept Family Med, Seoul, South Korea
[4] Dongguk Univ, Ilsan Hosp, Dept Family Med, Ctr Obes Metab & Nutr, Goyang, South Korea
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2019年 / 8卷 / 18期
基金
新加坡国家研究基金会;
关键词
cardiovascular disease risk factors; cardiovascular events; obesity; BODY-MASS INDEX; CORONARY-HEART-DISEASE; SUBCUTANEOUS ADIPOSE-TISSUE; MECHANISMS LINKING OBESITY; CAUSE-SPECIFIC MORTALITY; WAIST CIRCUMFERENCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; VISCERAL FAT; RISK-FACTOR;
D O I
10.1161/JAHA.119.013471
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Body mass index and waist circumference (WC) are commonly used metrics that reflect general obesity and abdominal obesity. However, the impact of general and abdominal obesity discrepancies on the risk for major adverse cardiac events (MACE) is less explored. Methods and Results-The study population was derived from the Korean National Health Insurance Service-Health Screening Cohort. Among 315 982 participants aged 40 years or older who underwent health examinations between 2008 and 2009, body mass index and WC were used to determine the obesity status. The participants were followed from January 1, 2010 for MACE until December 31, 2015. Cox proportional hazards models were used to evaluate the association of obesity and the risk of MACE. Compared with men who were not obese, those with abdominal obesity without general obesity (adjusted hazard ratio (aHR) 1.29, 95% CI 1.16-1.43), and general and abdominal obesity (aHR 1.20, 95% CI 1.12-1.29) had elevated risk of MACE, while those with general obesity without abdominal obesity (aHR 1.06, 95% CI 0.98-1.16) did not. Similarly, women with abdominal obesity without general obesity (aHR 1.13, 95% CI 1.03-1.24) and those with general and abdominal obesity (aHR 1.15, 95% CI 1.06-1.25) had increased risk of MACE, while those with general obesity without abdominal obesity (aHR 1.07, 95% CI 0.88-1.30) did not. Conclusions-Abdominal obesity without general obesity was associated with an elevated risk of major cardiovascular outcomes while general obesity without abdominal obesity did not. Concurrent determination of body mass index and WC may be beneficial for the accurate determination of future cardiovascular risk.
引用
收藏
页码:1 / 8
页数:13
相关论文
共 53 条
  • [1] Relationship between obesity, insulin resistance, and coronary heart disease risk
    Abbasi, F
    Brown, BW
    Lamendola, C
    McLaughlin, T
    Reaven, GM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (05) : 937 - 943
  • [2] The obesity epidemic
    Abelson, P
    Kennedy, D
    [J]. SCIENCE, 2004, 304 (5676) : 1413 - 1413
  • [3] Akil L, 2011, J HEALTH CARE POOR U, V22, P61, DOI 10.1353/hpu.2011.0166
  • [4] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. DIABETIC MEDICINE, 2006, 23 (05) : 469 - 480
  • [5] Waist circumference, BMI, smoking, and mortality in middle-aged men and women
    Bigaard, J
    Tjonneland, A
    Thomsen, BL
    Overvad, K
    Heitmann, BL
    Sorensen, TIA
    [J]. OBESITY RESEARCH, 2003, 11 (07): : 895 - 903
  • [6] General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis
    Carmienke, S.
    Freitag, M. H.
    Pischon, T.
    Schlattmann, P.
    Fankhaenel, T.
    Goebel, H.
    Gensichen, J.
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2013, 67 (06) : 573 - 585
  • [7] Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease
    Dagenais, GR
    Yi, QL
    Mann, JFE
    Bosch, J
    Pogue, J
    Yusuf, S
    [J]. AMERICAN HEART JOURNAL, 2005, 149 (01) : 54 - 60
  • [8] Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
    de Jong, Marit
    van der Worp, H. Bart
    van der Graaf, Yolanda
    Visseren, Frank L. J.
    Westerink, Jan
    [J]. CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [9] DONAHUE RP, 1987, LANCET, V1, P821
  • [10] Mechanisms linking obesity to hypertension
    Dorresteijn, J. A. N.
    Visseren, F. L. J.
    Spiering, W.
    [J]. OBESITY REVIEWS, 2012, 13 (01) : 17 - 26